An educated thought is that you personally would be estimating the effectiveness of stem call treatment higher if it was multistem being used in the trial.
But yes, with mortality rates being lower overall, there's a reasonable chance what your saying could occur.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.79 |
Change
0.065(3.77%) |
Mkt cap ! $2.297B | |||
| Open | High | Low | Value | Volume |
| $1.73 | $1.81 | $1.70 | $7.807M | 4.430M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39187 | $1.79 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.81 | 12767 | 4 |
View Market Depth
| Last trade - 16.10pm 17/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |